Article

LA Times on 2022-06-17 05:41

Pfizer says its COVID pill doesn’t work for healthier patients

Pfizer plans to stop enrollment in a study of its COVID-19 drug in patients who aren’t at high risk of severe disease.

Related news

HEU Drug Regulator OKs Pfizer COVID Pill for High-Risk Patients hamodia.com
Europe , United States , Belgium , Germany , Italy
Tucker Carlson Falsely Suggests Pfizer Admitted Its Vaccine ‘Doesn’t Work’Forbes
Washington
Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous Seattle Times
Pfizer asks U.S. officials to OK promising covid-19 pill Arkansas Online
Pfizer asks US officials to OK promising COVID-19 pill Star Telegram
Washington , United Kingdom , United States
Pfizer asks U.S. officials to OK promising COVID-19 pill staradvertiser.com
United Kingdom , United States
Pfizer seeks emergency use authorization for Covid-19 antiviral pill POLITICO
Pfizer wants approval for promising COVID-19 pill reviewjournal.com
United Kingdom , United States , Pill unter dem Bache
Pfizer submits its COVID-19 pill for US authorization timesofisrael.com
United Kingdom , Israel , United States
Pfizer, drugmakers call for reversal of Texas abortion pill ruling New York Post
Idaho , Texas
Pfizer sees strong demand for COVID pill as profits surge timesofisrael.com
Israel , United States , Greece , Thessaloniki , New York
Pfizer COVID pill sharply reduced hospitalizations and deaths and appears to work against omicron, company says Alaska Dispatch News
Midwest , Anchorage , Alaska
MPfizer says Paxlovid doesn't help COVID-19 patients unless they are high risk3 min read marketwatch.com
Infectious Diseases , Phase 2
Israel is not among the 90 countries in talks with Pfizer over COVID pill timesofisrael.com
Asia , Pennsylvania , Russia , United Kingdom , Jerusalem
Pfizer seeks approval for COVID-19 treatment pill, eyes rollout in coming weeks nj.com
California